(Q51114179)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Therapy monitoring of skeletal metastases with whole-body diffusion MRI (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

Andreas Makris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Peter Gall

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Nina Tunariu

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Johann S de Bono

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

10 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

Journal of Magnetic Resonance Imaging

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1049-1078

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510426%20AND%20SRC:MED&resulttype=core&format=json

Metastases in carcinoma; analysis of 1000 autopsied cases

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Clinical features of metastatic bone disease and risk of skeletal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Cancer to bone: a fatal attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Bisphosphonates for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

New molecular targets in bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Novel bone-targeted strategies in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Assessment of therapeutic response in patients with metastatic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Bone imaging in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Serum tumor markers in breast cancer: are they of clinical value?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Biochemical markers and skeletal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Circulating tumor cells: evolving evidence and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Utilizing circulating tumor cells: challenges and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Evaluation of DCE-MRI postprocessing techniques to assess metastatic bone marrow in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Diffusion and perfusion imaging of bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Imaging response to systemic therapy for bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

¹⁸F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Prostate cancer: role of SPECT and PET in imaging bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

21 January 2018

Tumor receptor imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Positron emission tomography and bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Whole-body MRI for the staging and follow-up of patients with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

MR imaging of bone metastases and choice of sequence: spin echo, in-phase gradient echo, diffusion, and contrast medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Dixon techniques for water and fat imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Whole-body diffusion-weighted MR imaging in cancer: current status and research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Bony metastases: assessing response to therapy with whole-body diffusion MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Evaluation of dual-source parallel RF excitation for diffusion-weighted whole-body MR imaging with background body signal suppression at 3.0 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Normal lumbar vertebrae: anatomic, age, and sex variance in subjects at proton MR spectroscopy--initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Magnetic resonance imaging of bone marrow in oncology, Part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

MR imaging insights into skeletal maturation: what is normal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Apparent Diffusion Coefficient in Invasive Ductal Breast Carcinoma: Correlation with Detailed Histologic Features and the Enhancement Ratio on Dynamic Contrast-Enhanced MR Images

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Acute vertebral body compression fractures: discrimination between benign and malignant causes using apparent diffusion coefficients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Diffusion MR imaging for monitoring of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Death by design: apoptosis, necrosis and autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Chemotherapeutic approaches for targeting cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

The proliferation rate paradox in antimitotic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Apoptosis: a review of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

The convergence of radiation and immunogenic cell death signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Tumors in Pediatric Patients at Diffusion-weighted MR Imaging: Apparent Diffusion Coefficient and Tumor Cellularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

The CT flare response of metastatic bone disease in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548

Computed diffusion-weighted MR imaging may improve tumor detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24548